BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30236605)

  • 1. Prevention and management of recurrent postoperative Hirschsprung's disease obstructive symptoms and enterocolitis: Systematic review and meta-analysis.
    Soh HJ; Nataraja RM; Pacilli M
    J Pediatr Surg; 2018 Dec; 53(12):2423-2429. PubMed ID: 30236605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis.
    Nakamura H; Lim T; Puri P
    Pediatr Surg Int; 2018 Feb; 34(2):189-193. PubMed ID: 28983778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through.
    Rentea RM; Noel-MacDonnell JR; Bucher BT; Dorman MR; Lautz TB; Pruitt LCC; Oyetunji TA
    J Surg Res; 2021 May; 261():95-104. PubMed ID: 33422904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics prevent Hirschsprung's disease-associated enterocolitis: a prospective multicenter randomized controlled trial.
    Wang X; Li Z; Xu Z; Wang Z; Feng J
    Int J Colorectal Dis; 2015 Jan; 30(1):105-10. PubMed ID: 25370155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis.
    Ahmad H; Rentea RM; Knaus ME; Wilbur JG; Halaweish I; Langer JC; Levitt MA; Wood RJ
    J Pediatr Surg; 2022 Aug; 57(8):1453-1457. PubMed ID: 34991869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirschsprung's disease. Identification of risk factors for enterocolitis.
    Teitelbaum DH; Qualman SJ; Caniano DA
    Ann Surg; 1988 Mar; 207(3):240-4. PubMed ID: 2964227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in Hirschsprung's-associated enterocolitis.
    Pontarelli EM; Ford HR; Gayer CP
    Curr Gastroenterol Rep; 2013 Aug; 15(8):340. PubMed ID: 23857117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical risk factors of hirschsprung-associated enterocolitis. II: Postoperative enterocolitis.
    Sarioğlu A; Tanyel FC; Büyükpamukçu N; Hiçsönmez A
    Turk J Pediatr; 1997; 39(1):91-8. PubMed ID: 10868199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung's disease.
    Ruttenstock E; Puri P
    Pediatr Surg Int; 2010 Nov; 26(11):1101-5. PubMed ID: 20711596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal irrigations for the prevention of postoperative enterocolitis in Hirschsprung's disease.
    Marty TL; Seo T; Sullivan JJ; Matlak ME; Black RE; Johnson DG
    J Pediatr Surg; 1995 May; 30(5):652-4. PubMed ID: 7623219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevention and treatment of enterocolitis in children with Hirschsprung's disease].
    Honchar VV
    Lik Sprava; 2000 Mar; (2):69-72. PubMed ID: 10862481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologically assessed grade of Hirschsprung-associated enterocolitis in resected colon in children with Hirschsprung's disease predicts postoperative bowel function.
    Cheng S; Wang J; Pan W; Yan W; Shi J; Guan W; Wang Y; Cai W
    J Pediatr Surg; 2017 Nov; 52(11):1776-1781. PubMed ID: 28385428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis.
    Gosain A; Frykman PK; Cowles RA; Horton J; Levitt M; Rothstein DH; Langer JC; Goldstein AM;
    Pediatr Surg Int; 2017 May; 33(5):517-521. PubMed ID: 28154902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.
    Langer JC; Rollins MD; Levitt M; Gosain A; Torre L; Kapur RP; Cowles RA; Horton J; Rothstein DH; Goldstein AM;
    Pediatr Surg Int; 2017 May; 33(5):523-526. PubMed ID: 28180937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utilization of botulinum toxin for Hirschsprung disease.
    Svetanoff WJ; Lim-Beutal IIP; Wood RJ; Levitt MA; Rentea RM
    Semin Pediatr Surg; 2022 Apr; 31(2):151161. PubMed ID: 35690464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    El-Sawaf M; Siddiqui S; Mahmoud M; Drongowski R; Teitelbaum DH
    J Pediatr Surg; 2013 Jan; 48(1):111-7. PubMed ID: 23331802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impacts of delayed diagnosis of Hirschsprung's disease in newborn infants.
    Lee CC; Lien R; Chiang MC; Yang PH; Chu SM; Fu JH; Lai JY
    Pediatr Neonatol; 2012 Apr; 53(2):133-7. PubMed ID: 22503261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Hirschsprung-associated enterocolitis in patients with Hirschsprung disease.
    Hagens J; Reinshagen K; Tomuschat C
    Pediatr Surg Int; 2022 Jan; 38(1):3-24. PubMed ID: 34595554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical alert card: a valuable tool in the management of Hirschsprung's-associated enterocolitis from parental perspective.
    Muntean A; Stoica I; Matcovici M; Costigan A; Orr S; Kearney M; Gillick J
    Pediatr Surg Int; 2020 Dec; 36(12):1423-1428. PubMed ID: 33034716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Insights into the Pathogenesis of Hirschsprung's-associated Enterocolitis.
    Jiao CL; Chen XY; Feng JX
    Chin Med J (Engl); 2016 Jun; 129(12):1491-7. PubMed ID: 27270548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.